Actively Recruiting

Age: 10Years - 30Years
All Genders
ID07015632

Quantitative Analysis of Upper Extremity Functional Movement in Patients With Duchenne Muscular Dystrophy

Led by Seoul National University Hospital · Updated on 2025-06-13

30

Participants Needed

1

Research Sites

69 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are analyzing changes in upper arm movement over time in children and young adults with Duchenne Muscular Dystrophy (DMD). This observational study focuses on improving evaluation methods for upper limb function in non-ambulatory DMD patients by using clinical tests and advanced video analysis. Thirty participants will be studied to better understand functional changes and support future care. Participants will be assessed at three visits: baseline, 6 months, and 12 months. At each visit, clinical assessments including the Performance of the Upper Limb module 2.0 (PUL 2.0), Brooke Scale, and grip strength tests will be performed. These evaluations will be combined with computer vision video analysis and machine learning to provide detailed movement data. During the study, participants will undergo clinical exams and video recordings to track upper limb function. The main measure is the PUL 2.0 score over time, with secondary measures including Brooke Scale scores and grip strength. Safety monitoring is in place, patient data confidentiality is maintained, and compensation is available if any adverse effects occur. The total participation lasts about one year with three assessment visits.

CONDITIONS

Brief Title

ML-Based Multi-Sensor Fall Risk Screening in DMD

Who Can Participate

Age: 10Years - 30Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals with a confirmed genetic diagnosis of Duchenne Muscular Dystrophy (DMD)
  • Age over 10 and under 30 years
  • Brooke Scale score between 2 and 5
  • Manual muscle test grade below 3 for shoulder abduction muscles
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide informed consent
  • Brooke Scale score of 1 or 6
  • Cognitive impairments that significantly limit participation in assessments

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Monitoring

Duration - 12 months

Participants undergo clinical assessments and video analysis to evaluate upper limb function using the Performance of the Upper Limb, Brooke Scale, and grip strength tests.

3 visits at baseline, 6 months, and 12 months

Trial Site Locations

Total: 1 location

1

Seoul National University Hospital

Seoul, Jongno, South Korea, 03080

Actively Recruiting

Loading map...

Research Team

J

JungHyun Kim, prof

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Phase 3 Study of Intravenous DYNE-251 Every 4 Weeks in Amb...

Duchenne Muscular Dystrophy (DMD)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here